Background: Breast cancer in men accounts for around 1 % of all cases of the disease. The study aimed to identify histopathological parameters and selected biomarkers in men with breast cancer. Material and method: Retrospective study of archival material from 53 men diagnosed with breast cancer at the department of pathology, Haukeland University Hospital, in the period 1996-2020. The prevalence of the oestrogen receptor (ER), progesterone receptor (PGR) and Human Epidermal Growth Factor (HER2) biomarkers was examined. Results: Median age at time of diagnosis was 72 years. Median tumour diameter was 24 mm. Forty-nine tumours were classified histologically as invasive carcinoma of no special type (NST), 29 tumours were histologic grade 2 and 18 were grade 3. Fifty-two tumours were ER positive, 39 were PGR positive and four were HER2 positive. Twenty-five patients had lymph node metastases. Interpretation: Our findings indicate that men with breast cancer are diagnosed at an older age than women, and that men have a more advanced stage than women at the time of diagnosis. The histopathology and expression of biomarkers of breast cancer differ between men and women.
Biomarkers, Tumor , Breast Neoplasms, Male , Receptor, ErbB-2 , Receptors, Estrogen , Receptors, Progesterone , Humans , Male , Aged , Middle Aged , Retrospective Studies , Receptor, ErbB-2/metabolism , Receptors, Progesterone/metabolism , Breast Neoplasms, Male/pathology , Breast Neoplasms, Male/diagnosis , Receptors, Estrogen/metabolism , Aged, 80 and over , Adult , Female , Lymphatic Metastasis , Neoplasm Staging , Neoplasm Grading , Age Factors
